Global Blood Transfusion Diagnostics Market size will expand significantly over 2023-2032. The flourishing medical device industry globally is presenting growth pathways for the market. Many governments in developed and developing countries are investing significant amounts into medical devices to expand their healthcare infrastructure. This, in consequence, has propelled the demand for blood transfusion diagnostic products, thus, contributing to market revenue. To illustrate, recent IBEF estimates suggest that the medical device market in India could be worth USD 50 billion by 2025.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5607
The overall blood transfusion diagnostics industry is classified based on product, application, end-use, and region.
The market share from the instruments segment will grow at a considerable CAGR from 2023 to 2032. Recent advancements in blood transfusion instruments have improved the safety and efficacy of the transfusion process. In fact, automated blood component separators and cell salvage devices now allow for the extraction of specific blood components, reducing the need for whole blood transfusions and minimizing the risk of adverse reactions. Moreover, a remarkable rise in people undergoing surgical procedures has increased the need for blood transfusion instruments, such as blood bags, infusion pumps, and others, driving business growth.
In terms of application, the blood transfusion diagnostics market value from the blood grouping segment will grow substantially through 2032. Consistent advancements in blood grouping are contributing to segment growth. Molecular blood group genotyping has revolutionized transfusion medicine by providing a DNA-based method for determining blood types. This technique involves identifying genetic variations and specific alleles associated with blood groups, allowing for precise and reliable blood typing.
Based on end use, the blood transfusion diagnostics market from the blood banks segment will register huge gains over 2023-2032. Growing number of blood banks across the world is creating a broad scope for segment growth. Moreover, the high availability of advanced equipment in these facilities has made transfusion easier, further strengthening the segment outlook. Moreover, the growing need for rigorous screening and testing procedures to ensure the safety of donated blood has increased the demand for blood banks, thus, favoring market growth.
Asia Pacific blood transfusion diagnostics industry will grow at a significant CAGR from 2023 to 2032. Growing healthcare industry, coupled with the increasing geriatric population in the region, is working in favor of industry growth. As per WHO, over 28% of people in China will be over 60 years of age by 2040. Moreover, the rising number of blood banks in the region has further increased the need for blood transfusion diagnostics.
Request for customization @ https://www.gminsights.com/roc/5607
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Blood transfusion diagnostics industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use trends
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/blood-transfusion-diagnostics-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
Global Blood Transfusion Diagnostics Market Information, by product (Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations, others) by Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test, others) by end user (Hospitals, Clinics, Blood banks, Laboratories) - Forecast till 2027Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens (Germany), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).are some of the prominent players at the forefront of competition in the global Blood Transfusion Diagnostics market and top seven players are profiled in MRFR Analysis.
However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1126Global Blood Transfusion Diagnostics Market - Competitive AnalysisThere is a significant increase in the number of the company offering blood transfusion diagnostics.
Some major companies are trying to focus on new and advanced tests & products to gain the market.
Whereas, some are has used the technique of acquisition and collaboration to gain the market.Hoffmann-La Roche AG:August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics.
This merger will further strengthen the global presence of the company.August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia.
The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.Bio-Rad Laboratories, Inc.:July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.Global Blood Transfusion Diagnostics Market - Regional AnalysisGlobally, Americas account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America.
A recent report published by TheBusinessResearchCompany on Blood Transfusion Diagnostics Market provides in-depth analysis of segments and sub-segments in the global as well as regional.The Blood Transfusion Diagnostics Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global blood transfusion diagnostics market.
the report covers the blood transfusion diagnostics market’s segments- instruments and kits, reagents, hospitals, diagnostic laboratories, blood banks, plasma fractionation companies, western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test, blood grouping, and disease screening.Blood Transfusion Diagnostics Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency, and reduce turnaround time of the results.
